Inventor · disambiguated record
Jeffrey Jonas
Also filed as: JONAS JEFFREY · JONAS JEFFREY M · JONAS JEFFREY MARTIN
2 granted patents·21 pending applications·41 citations·filing 2002–2025
61Inventor score
Files withSAGE THERAPEUTICS INC14FOREST LAB HOLDINGS LTD3FOREST LABORATORIES2JONAS JEFFREY1JONAS JEFFREY M1
Top patents by PatentIndex Score
23 records- 0188US8221779B2Compositions and methods for the delivery of poorly water soluble drugs and methods of treatmentJONAS JEFFREY M·Filed 2009·Granted Jul 17, 2012·39 cites·21 claims
- 0279US2025339447A119-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0372US2023201224A119-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0472US2022323462A119-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0570US2025387414A119-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0669US7569605B2Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropionFOREST LAB HOLDINGS LTD·Filed 2006·Granted Aug 4, 2009·2 cites·9 claims
- 0768US2010081723A1Memantine For The Treatment Of Childhood Behavioral DisordersFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 0866US2009081259A11-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affectMERZ PHARMA GMBH & CO KGAA·Filed 2008·Application pending·0 cites
- 0961US2022110949A1A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1059US2020113917A119-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1159US2021113590A1Compositions and methods for treating cns disordersSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1258US2021338692A1A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1358US2025295674A1Neuroactive steroids for treatment of cns-related disordersSAGE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1457US2024216396A1Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating femaleSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1555US2006205822A11-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affectFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 1654US2024245711A1A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid for the treatment of major depressive disorderSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1754US2024216395A119-nor c3,3-disubstituted c21 -n-pyrazolyl steroid for use in treating major depressive disorder and postpartum depressionSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1853US2018311258A1Compositions and methods for treating cns disordersSAGE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1952US2009264522A1Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropionFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 2050US2023018765A1A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2145US2006079582A1Memantine for the treatment of childhood behavioral disordersJONAS JEFFREY·Filed 2005·Application pending·0 cites
- 2245US2006035888A1Memantine as adjunctive treatment to atypical antipsychotic in schizophrenia patientsFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 2342US2003087837A1Compositions and methods for delivery of poorly water soluble drugs and methods of treatmentFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Jonas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →